Clinical and laboratory features compared between JAK2 exon12 and JAK2 V617F mutated polycythemia vera  

作　　者：LIU Dan 刘丹(State Key Experiment Hematol Lab,Natl Clin Blood Dis Res Cen-ter,Instit Hematol&Blood Dis Hosp,CAMS&PUMC,Tianjin 300020)

机构地区：[1]State Key Experiment Hematol Lab,Natl Clin Blood Dis Res Cen-ter,Instit Hematol&Blood Dis Hosp,CAMS&PUMC,Tianjin 300020

出　　处：《China Medical Abstracts(Internal Medicine)》2022年第2期123-123,共1页中国医学文摘（内科学分册（英文版）

摘　　要：Objective To compare clinical and laboratory features between JAK2 exon12 and JAK2 V617F mutated polycythemia vera (PV).Method We collected data from 570 consecutive newly-diagnosed subjects with PV and JAK2 mutation, and compared clinical and laboratory features between patients with JAK2 exon12 and JAK2V617F mutation.Results543 (95.3%) subjects harboured JAK2 V617F mutation (JAK2 V617F cohort).

关 键 词：JAK2 V617F JAK2V617F 

分 类 号：R555.1[医药卫生—血液循环系统疾病]